Osada M - Search Results

1

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

Yamashita K, Upadhyay S, Osada M, Hoque MO, Xiao Y, Mori M, Sato F, Meltzer SJ, Sidransky D. Yamashita K, et al. Among authors: osada m. Cancer Cell. 2002 Dec;2(6):485-95. doi: 10.1016/s1535-6108(02)00215-5. Cancer Cell. 2002. PMID: 12498717 Free article.

2

Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.

Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D. Tokumaru Y, et al. Among authors: osada m. Cancer Res. 2004 Sep 1;64(17):5982-7. doi: 10.1158/0008-5472.CAN-04-0993. Cancer Res. 2004. PMID: 15342377

3

PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.

Mandelker DL, Yamashita K, Tokumaru Y, Mimori K, Howard DL, Tanaka Y, Carvalho AL, Jiang WW, Park HL, Kim MS, Osada M, Mori M, Sidransky D. Mandelker DL, et al. Among authors: osada m. Cancer Res. 2005 Jun 1;65(11):4963-8. doi: 10.1158/0008-5472.CAN-04-3923. Cancer Res. 2005. PMID: 15930319

4

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

Kim MS, Yamashita K, Baek JH, Park HL, Carvalho AL, Osada M, Hoque MO, Upadhyay S, Mori M, Moon C, Sidransky D. Kim MS, et al. Among authors: osada m. Cancer Res. 2006 Apr 1;66(7):3409-18. doi: 10.1158/0008-5472.CAN-05-1608. Cancer Res. 2006. PMID: 16585162

5

PGP9.5 methylation in diffuse-type gastric cancer.

Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: osada m. Cancer Res. 2006 Apr 1;66(7):3921-7. doi: 10.1158/0008-5472.CAN-05-1511. Cancer Res. 2006. PMID: 16585221

6

A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.

Kim MS, Yamashita K, Chae YK, Tokumaru Y, Chang X, Zahurak M, Osada M, Park HL, Chuang A, Califano JA, Sidransky D. Kim MS, et al. Among authors: osada m. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6658-65. doi: 10.1158/1078-0432.CCR-07-1178. Clin Cancer Res. 2007. PMID: 18006766

7

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: osada m. Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213. Mol Cancer Res. 2008. PMID: 18234960

8

DCC promoter hypermethylation in esophageal squamous cell carcinoma.

Park HL, Kim MS, Yamashita K, Westra W, Carvalho AL, Lee J, Jiang WW, Baek JH, Liu J, Osada M, Moon CS, Califano JA, Mori M, Sidransky D. Park HL, et al. Among authors: osada m. Int J Cancer. 2008 Jun 1;122(11):2498-502. doi: 10.1002/ijc.23434. Int J Cancer. 2008. PMID: 18302152

9

The role of PGP9.5 as a tumor suppressor gene in human cancer.

Tokumaru Y, Yamashita K, Kim MS, Park HL, Osada M, Mori M, Sidransky D. Tokumaru Y, et al. Among authors: osada m. Int J Cancer. 2008 Aug 15;123(4):753-9. doi: 10.1002/ijc.23354. Int J Cancer. 2008. PMID: 18512240 Free PMC article.

10

DeltaNp63alpha up-regulates the Hsp70 gene in human cancer.

Wu G, Osada M, Guo Z, Fomenkov A, Begum S, Zhao M, Upadhyay S, Xing M, Wu F, Moon C, Westra WH, Koch WM, Mantovani R, Califano JA, Ratovitski E, Sidransky D, Trink B. Wu G, et al. Among authors: osada m. Cancer Res. 2005 Feb 1;65(3):758-66. Cancer Res. 2005. PMID: 15705872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters